NKTR
NASDAQ
US
Nektar Therapeutics - Common Stock
$76.99
▲ +$1.28
(+1.69%)
Vol 553K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$860.0M
ROE
-139.4%
Margin
-184.9%
D/E
0.00
Beta
1.29
52W
$6–$67
Wall Street Consensus
16 analysts · Apr 20267
Strong Buy
7
Buy
2
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 75.0%
Next Report
May 06, 2026
EPS Estimate: $-1.76
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-1.76 | — | — |
| Dec 2025 | $-2.52 | $-1.78 | +$0.74 |
| Sep 2025 | $-2.74 | $-1.87 | +$0.87 |
| Jun 2025 | $-3.10 | $-2.95 | +$0.15 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -253.3% | -253.3% | -253.3% | -139.4% | -139.4% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -372.2% | -157.2% | -157.2% | -157.2% | -184.9% | -184.9% |
| Gross Margin | 100.0% | 83.4% | 83.4% | 83.4% | 87.3% | 87.3% |
| D/E Ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 2.61 | 2.61 | 2.61 | 2.61 | 4.24 | 4.24 |
Key Ratios
ROA (TTM)
-43.3%
P/S (TTM)
13.74
P/B
2.8
EPS (TTM)
$-7.58
CF/Share
$-1.50
Rev Growth 3Y
-1.2%
52W High
$66.92
52W Low
$6.48
$6.48
52-Week Range
$66.92
How does NKTR compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
NKTR valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
13.7
▲
178%
above
peers
(5.0)
vs Peers
vs Industry
Pricier
P/B ratio
2.8
▲
33%
above
peers
(2.1)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
NKTR profitability vs Pharmaceuticals peers
ROE
-139.4%
▼
157%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
-184.9%
▼
290%
below
peers
(-47.4%)
vs Peers
vs Industry
Weak
Gross margin
87.3%
▲
28%
above
peers
(68.3%)
vs Peers
vs Industry
Weak
ROA
-43.3%
▼
16%
below
peers
(-37.4%)
vs Peers
vs Industry
Below avg
NKTR financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
4.2
▲
26%
above
peers
(3.4)
vs Peers
vs Industry
Below avg
Beta
1.3
▲
38%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
NKTR fundamentals radar
NKTR
Peer median
Industry
NKTR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NKTR vs peers: key metrics
Latest News
No related news yet